Welfringer P, Taron F, Bertrand D
Département d'Anesthésie-Réanimation, Hôpital Central, Nancy.
Cah Anesthesiol. 1989 Jan-Feb;37(1):11-6.
The clinical effects of a propofol-alfentanil association were studied in fifteen patients ASA II (mean age 50.1 +/- 14.1) anaesthetized for E.N.T. endoscopy after informed consent. All the patients received an intramuscular premedication with 0.10 to 0.15 mg.kg-1 midazolam. Propofol 2.5 mg.kg-1 was injected in a peripheral venous line with alfentanil 10 micrograms.kg-1, followed by continuous automatic injection of propofol at a dose of 5 to 10 mg.kg.h-1 and alfentanil 5 micrograms.kg-1 given just before suspension. After induction and during maintenance of anaesthesia, the patients were allowed to breathe oxygen spontaneously O2 assisted when apneic. The following variables were studied before induction (to), after induction (t1), during suspension (t2) and when stopping the infusion (t3): haemodynamic parameters using an invasive method and blood gases. Statistical analysis was performed using the Student's test for paired samples. Surgical conditions and anaesthetic quality were good with early recovery of consciousness and return of all reflexes. After an initial period of cardio vascular depression, the haemodynamic parameters did not vary much during the anaesthesia and propofol-alfentanil appeared to limit considerably the hypertension due to laryngoscopy. However, there was a moderate degree of hypercapnia (p less than 0.001) in most patients, giving evidence of some respiratory depression and possibly a greater depth of anaesthesia than desirable. Indeed, the doses of alfentanil required seemed to be more important with propofol because of a probably interference between the two drugs; the doses of these drugs should therefore be modified according to the length of surgery.
在15例美国麻醉医师协会(ASA)分级为II级(平均年龄50.1±14.1岁)的患者中,在获得知情同意后,对其进行耳鼻喉内镜检查麻醉时,研究了丙泊酚 - 阿芬太尼联合用药的临床效果。所有患者均接受了0.10至0.15mg·kg⁻¹咪达唑仑的肌肉注射术前用药。将2.5mg·kg⁻¹丙泊酚与10μg·kg⁻¹阿芬太尼经外周静脉管路注射,随后以5至10mg·kg·h⁻¹的剂量持续自动注射丙泊酚,并在暂停前给予5μg·kg⁻¹阿芬太尼。在诱导麻醉和维持麻醉期间,患者自主呼吸氧气,呼吸暂停时给予氧气辅助。在诱导前(t₀)、诱导后(t₁)、暂停期间(t₂)和停止输注时(t₃)研究了以下变量:采用有创方法测量的血流动力学参数和血气。使用配对样本的Student检验进行统计分析。手术条件和麻醉质量良好,意识恢复早且所有反射恢复。在最初的心血管抑制期后,麻醉期间血流动力学参数变化不大,丙泊酚 - 阿芬太尼似乎能显著减轻喉镜检查引起的高血压。然而,大多数患者存在中度高碳酸血症(p<0.001),表明存在一定程度的呼吸抑制,并且麻醉深度可能比预期更深。事实上,由于两种药物之间可能存在相互干扰,丙泊酚使用时所需的阿芬太尼剂量似乎更大;因此,这些药物的剂量应根据手术时长进行调整。